- Home
- AMLX vs STGW Comparison
AMLX vs STGW Comparison
Compare AMLX & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- STGW
- Stock Information
- Founded
- AMLX 2014
- STGW 1980
- Country
- AMLX United States
- STGW United States
- Employees
- AMLX N/A
- STGW N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- STGW
- Sector
- AMLX Health Care
- STGW
- Exchange
- AMLX Nasdaq
- STGW Nasdaq
- Market Cap
- AMLX 1.3B
- STGW 1.4B
- IPO Year
- AMLX 2022
- STGW N/A
- Fundamental
- Price
- AMLX $14.79
- STGW $5.40
- Analyst Decision
- AMLX Strong Buy
- STGW Buy
- Analyst Count
- AMLX 7
- STGW 6
- Target Price
- AMLX $17.43
- STGW $8.46
- AVG Volume (30 Days)
- AMLX 1.5M
- STGW 5.1M
- Earning Date
- AMLX 11-06-2025
- STGW 11-06-2025
- Dividend Yield
- AMLX N/A
- STGW N/A
- EPS Growth
- AMLX N/A
- STGW 1954.71
- EPS
- AMLX N/A
- STGW 0.06
- Revenue
- AMLX N/A
- STGW $2,890,264,000.00
- Revenue This Year
- AMLX N/A
- STGW $4.18
- Revenue Next Year
- AMLX N/A
- STGW $9.16
- P/E Ratio
- AMLX N/A
- STGW $95.13
- Revenue Growth
- AMLX N/A
- STGW 6.75
- 52 Week Low
- AMLX $2.60
- STGW $4.03
- 52 Week High
- AMLX $16.96
- STGW $8.18
- Technical
- Relative Strength Index (RSI)
- AMLX 60.27
- STGW 57.27
- Support Level
- AMLX $11.93
- STGW $4.70
- Resistance Level
- AMLX $15.09
- STGW $6.88
- Average True Range (ATR)
- AMLX 1.00
- STGW 0.36
- MACD
- AMLX 0.14
- STGW 0.06
- Stochastic Oscillator
- AMLX 89.70
- STGW 33.41
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About STGW Stagwell Inc.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.